John William Robinson
Engineers at Monroe Dr, Boulder, CO
License number
Colorado 62286
Issued Date
Jun 17, 2005
Renew Date
Jun 17, 2005
Type
Engineer Intern
Address
Address
4330 Monroe Dr APT D, Boulder, CO 80303
Professional information
Triazolopyridine Compounds As Pim Kinase Inhibitors
US Patent:
2014004, Feb 13, 2014
Filed:
Oct 15, 2013
Appl. No.:
14/054459
Inventors:
Robert Kirk DeLisle - Lyons CO, US
Julie Marie Hicks - Erie CO, US
Erik James Hicken - Boulder CO, US
Joseph P. Lyssikatos - Piedmont CA, US
Fredrik P. Marmsater - Boulder CO, US
Mark C. Munson - Acton MA, US
John E. Robinson - Boulder CO, US
Qian Zhao - El Cerrito CA, US
Julie Marie Hicks - Erie CO, US
Erik James Hicken - Boulder CO, US
Joseph P. Lyssikatos - Piedmont CA, US
Fredrik P. Marmsater - Boulder CO, US
Mark C. Munson - Acton MA, US
John E. Robinson - Boulder CO, US
Qian Zhao - El Cerrito CA, US
Assignee:
Array BioPharma Inc. - Boulder CO
International Classification:
C07D 471/04
US Classification:
5142332, 51425306, 514303
Abstract:
Provided herein are methods of treating diseases mediated by PIM-1 and/or PIM-2 and/or PIM-3 kinases by administering to a mammal in need thereof a therapeutically effective amount of a compound of Formula I:in which B, R, R, R, R, R, R, R, R, Rand Rhave the meanings given in the specification.
Triazolopyridine Compounds As Pim Kinase Inhibitors
US Patent:
2014004, Feb 13, 2014
Filed:
Oct 18, 2013
Appl. No.:
14/057882
Inventors:
Laura L. Celeste - Gaithersburg MD, US
T. Gregg Davis - Boulder CO, US
Robert Kirk DeLisle - Lyons CO, US
Julie Marie Hicks - Erie CO, US
Stefan D. Gross - Sudbury MA, US
Erik James Hicken - Boulder CO, US
Leila J. Jackson - Aurora CO, US
Nicholas C. Kallan - Louisville CO, US
Joseph P. Lyssikatos - Piedmont CA, US
Fredrik P. Marmsater - Boulder CO, US
Mark C. Munson - Acton MA, US
Jed Pheneger - Boulder CO, US
Bryson Rast - Westminster CO, US
John E. Robinson - Boulder CO, US
Stephen T. Schlachter - Dallas TX, US
George T. Topalov - Pittsburg PA, US
A. Dale Wright - Boulder CO, US
Qian Zhao - El Cerrito CA, US
T. Gregg Davis - Boulder CO, US
Robert Kirk DeLisle - Lyons CO, US
Julie Marie Hicks - Erie CO, US
Stefan D. Gross - Sudbury MA, US
Erik James Hicken - Boulder CO, US
Leila J. Jackson - Aurora CO, US
Nicholas C. Kallan - Louisville CO, US
Joseph P. Lyssikatos - Piedmont CA, US
Fredrik P. Marmsater - Boulder CO, US
Mark C. Munson - Acton MA, US
Jed Pheneger - Boulder CO, US
Bryson Rast - Westminster CO, US
John E. Robinson - Boulder CO, US
Stephen T. Schlachter - Dallas TX, US
George T. Topalov - Pittsburg PA, US
A. Dale Wright - Boulder CO, US
Qian Zhao - El Cerrito CA, US
Assignee:
Array BioPharma Inc. - Boulder CO
International Classification:
C07D 471/04, C07D 451/06
US Classification:
51421021, 51421707, 5142332, 514272, 514303
Abstract:
Provided herein is a method of treating a PIM-1 and/or PIM-2 and/or PIM-3 kinase-mediated condition in a mammal, which comprises administering to said mammal a therapeutically effective amount of a compound of Formula I:in which A, B, R, R, R, R, R, R, R, and Rhave the meanings given in the specification.
Triazolopyridine Compounds As Pim Kinase Inhibitors
US Patent:
8575145, Nov 5, 2013
Filed:
Aug 18, 2009
Appl. No.:
13/059902
Inventors:
Shelley Allen - Boulder CO, US
Laura L. Celeste - Gaithersburg MD, US
T. Gregg Davis - Boulder CO, US
Robert Kirk DeLisle - Boulder CO, US
Julie Marie Greschuk - Boulder CO, US
Stefan D. Gross - Superior CO, US
Erik James Hicken - Boulder CO, US
Leila J. Jackson - Boulder CO, US
Nicholas C. Kallan - Boulder CO, US
Joseph P. Lyssikatos - Piedmont CO, US
Fredrik P. Marmsater - Boulder CO, US
Mark C. Munson - Boulder CO, US
Jed Pheneger - Boulder CO, US
Bryson Rast - Westminster CO, US
John E. Robinson - Boulder CO, US
Stephen T. Schlachter - Boulder CO, US
George T. Topalov - Boulder CO, US
A. Dale Wright - Boulder CO, US
Qian Zhao - Boulder CO, US
Laura L. Celeste - Gaithersburg MD, US
T. Gregg Davis - Boulder CO, US
Robert Kirk DeLisle - Boulder CO, US
Julie Marie Greschuk - Boulder CO, US
Stefan D. Gross - Superior CO, US
Erik James Hicken - Boulder CO, US
Leila J. Jackson - Boulder CO, US
Nicholas C. Kallan - Boulder CO, US
Joseph P. Lyssikatos - Piedmont CO, US
Fredrik P. Marmsater - Boulder CO, US
Mark C. Munson - Boulder CO, US
Jed Pheneger - Boulder CO, US
Bryson Rast - Westminster CO, US
John E. Robinson - Boulder CO, US
Stephen T. Schlachter - Boulder CO, US
George T. Topalov - Boulder CO, US
A. Dale Wright - Boulder CO, US
Qian Zhao - Boulder CO, US
Assignee:
Array BioPharma Inc. - Boulder CO
International Classification:
A61K 31/55, A61K 31/437, A61K 31/513, A61K 31/5377, C07D 471/04, A61P 35/00, A61P 25/00, A61P 29/00
US Classification:
51421021, 514303, 51421707, 514272, 5142332, 546119, 544331, 544127, 540597
Abstract:
Compounds of Formula (I), in which A, B, R, R, R, R, R, R, R, and Rhave the meanings given in the specification, are receptor tyrosine inhibitors useful in the treatment of immune cell-associated diseases and disorders, such as inflammatory and autoimmune diseases.
Triazolopyridine Compounds As Pim Kinase Inhibitors
US Patent:
8557809, Oct 15, 2013
Filed:
Aug 18, 2009
Appl. No.:
13/059881
Inventors:
Shelley Allen - Boulder CO, US
Robert Kirk DeLisle - Boulder CO, US
Julie Marie Greschuk - Boulder CO, US
Erik James Hicken - Boulder CO, US
Joseph P. Lyssikatos - Piedmont CA, US
Fredrik P. Marmsater - Boulder CO, US
Mark C. Munson - Boulder CO, US
John E. Robinson - Boulder CO, US
Qian Zhao - Boulder CO, US
Robert Kirk DeLisle - Boulder CO, US
Julie Marie Greschuk - Boulder CO, US
Erik James Hicken - Boulder CO, US
Joseph P. Lyssikatos - Piedmont CA, US
Fredrik P. Marmsater - Boulder CO, US
Mark C. Munson - Boulder CO, US
John E. Robinson - Boulder CO, US
Qian Zhao - Boulder CO, US
Assignee:
Array BioPharma Inc. - Boulder CO
International Classification:
A61K 31/5377, A61K 31/496, A61K 31/4709, C07D 471/04, A61P 35/02, A61P 29/00
US Classification:
5142332, 514303, 51425306, 546119, 544128, 544363
Abstract:
Compounds of Formula (I): I in which B, R, R, R, R, R, R, R, R, Rand Rhave the meanings given in the specification, are receptor tyrosine inhibitors useful in the treatment of diseases mediated by PIM-1 and/or PIM-2 and/or PIM-3 kinases.
Mitotic Kinesin Inhibtors And Methods Of Use Thereof
US Patent:
2014001, Jan 16, 2014
Filed:
Sep 19, 2013
Appl. No.:
14/031958
Inventors:
Eli M. Wallace - Boulder CO, US
Qian Zhao - Boulder CO, US
Shelley Allen - Boulder CO, US
Ellen Laird - Boulder CO, US
Joseph P. Lyssikatos - Boulder CO, US
John E. Robinson - Boulder CO, US
Christopher P. Corrette - Boulder CO, US
Robert Kirk DeLisle - Boulder CO, US
Walter C. Voegtli - Boulder CO, US
Qian Zhao - Boulder CO, US
Shelley Allen - Boulder CO, US
Ellen Laird - Boulder CO, US
Joseph P. Lyssikatos - Boulder CO, US
John E. Robinson - Boulder CO, US
Christopher P. Corrette - Boulder CO, US
Robert Kirk DeLisle - Boulder CO, US
Walter C. Voegtli - Boulder CO, US
Assignee:
Array BioPharma Inc. - Boulder CO
International Classification:
C07D 285/12, C07D 417/04
US Classification:
514363, 548136, 435375
Abstract:
This invention relates to inhibitors of mitotic kinesins, particularly KSP, and methods for producing these inhibitors. The invention also provides pharmaceutical compositions comprising the inhibitors of the invention and methods of utilizing the inhibitors and pharmaceutical compositions in the treatment and prevention of various disorders.
Triazolopyridine Compounds As Pim Kinase Inhibitors
US Patent:
2014000, Jan 2, 2014
Filed:
Feb 24, 2012
Appl. No.:
14/001657
Inventors:
James F. Blake - Boulder CO, US
Robert Kirk Delisle - Longmont CO, US
Lisa A. De Meese - Phoenix AZ, US
James M. Graham - Longmont CO, US
Yvan Le Huerou - Boulder CO, US
Michael Lyon - Eris CO, US
John E. Robinson - Boulder CO, US
Eli M. Wallace - Richardson TX, US
Bin Wang - Dallas TX, US
Rui Xu - Boulder CO, US
Robert Kirk Delisle - Longmont CO, US
Lisa A. De Meese - Phoenix AZ, US
James M. Graham - Longmont CO, US
Yvan Le Huerou - Boulder CO, US
Michael Lyon - Eris CO, US
John E. Robinson - Boulder CO, US
Eli M. Wallace - Richardson TX, US
Bin Wang - Dallas TX, US
Rui Xu - Boulder CO, US
Assignee:
ARRAY BIOPHARMA INC. - Boulder CO
International Classification:
C07D 471/04, C07D 491/048, C07D 487/10, C07D 487/04
US Classification:
514278, 546119, 514303, 546 89, 514291, 546 15
Abstract:
Compounds of Formula I: in which R, R, R, Rand Rhave the meanings given in the specification, are receptor tyrosine inhibitors useful in the treatment of diseases mediated by PIM-1 and/or PIM-2 and/or PIM-3 kinases.